From Global News.

Health Canada approved the first generic version of brand-name semaglutide drugs like Ozempic on Tuesday, becoming the first G7 country to do so.

Manufactured by Dr. Reddy’s Laboratories in India, the injectable medication has been approved for once-a-week treatment of Type 2 diabetes in adults.

The generic semaglutide drug is sold under the brand name “Obeda” in India and was submitted for review to Health Canada in early 2024.

Health reporter Katherine Ward looks at how the move could help more Canadians gain access to medication.

For more info, please go to https://globalnews.ca/news/11820779/canada-approves-1st-generic-ozempic-market/

Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Follow Global News on X HERE: http://bit.ly/1Toz8mt
Follow Global News on TikTok HERE: https://www.tiktok.com/@globalnews.ca?lang=en

#GlobalNews #ozempic